0f09e1e9_erican_College_of_Rheumatology__ACR_EULAR
[Quality Indicator] IF a patient is diagnosed with proliferative pSLE nephritis (WHO or ISN/RPS class III or IV), THEN therapy with corticosteroids combined with another immunosuppressant agent should be provided and documented within 1 month of this diagnosis, unless contraindicated. [ACR/EULAR] 
ACR
E U L A R
A C R
American College of Rheumatology
ACR/EULAR